Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure

Journal of General Virology

Volumn 94, Issue PART4, 2013, Pages 876-883

  Kajihara, Masahiro ^a   Nakayama, Eri ^a   Marzi, Andrea ^b   Igarashi, Manabu ^a   Feldmann, Heinz ^b   Takada, Ayato ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FURIN; PROTEIN VP40; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; CLONE; CONTROLLED STUDY; DELETION MUTANT; DISULFIDE BOND; MARBURG VIRUS; MUTATION RATE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR BINDING; VESICULAR STOMATITIS VIRUS; VIRAL EVASION; VIRAL PHENOMENA AND FUNCTIONS; VIRUS EXPRESSION; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS RELEASE; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84875648000     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.049114-0     Document Type: Article

References (41)

1. Amman, B. R., Carroll, S. A., Reed, Z. D., Sealy, T. K., Balinandi, S., Swanepoel, R., Kemp, A., Erickson, B. R., Comer, J. A. & other authors (2012). Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog 8, e1002877.
2. Brindley, M. A., Hughes, L., Ruiz, A., McCray, P. B., Jr, Sanchez, A., Sanders, D. A. & Maury, W. (2007). Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol 81, 7702-7709.
3. Dube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H. & White, J. M. (2009). The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J Virol 83, 2883-2891.
4. Dye, J. M., Herbert, A. S., Kuehne, A. I., Barth, J. F., Muhammad, M. A., Zak, S. E., Ortiz, R. A., Prugar, L. I. & Pratt, W. D. (2012). Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A 109, 5034-5039.
5. Feldmann, H., Will, C., Schikore, M., Slenczka, W. & Klenk, H. D. (1991). Glycosylation and oligomerization of the spike protein of Marburg virus. Virology 182, 353-356.
6. Feldmann, H., Nichol, S. T., Klenk, H. D., Peters, C. J. & Sanchez, A. (1994). Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 199, 469-473.
7. Fofana, I., Fafi-Kremer, S., Carolla, P., Fauvelle, C., Zahid, M. N., Turek, M., Heydmann, L., Cury, K., Hayer, J. & other authors (2012). Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. Gastroenterology 143, 223-233.
8. Francica, J. R., Varela-Rohena, A., Medvec, A., Plesa, G., Riley, J. L. & Bates, P. (2010). Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLoS Pathog 6, e1001098.
9. García-Barreno, B., Portela, A., Delgado, T., López, J. A. & Melero, J. A. (1990). Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. EMBO J 9, 4181-4187.
10. Hangartner, L., Zinkernagel, R. M. & Hengartner, H. (2006). Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6, 231-243.
11. Holland, J. J., Domingo, E., de la Torre, J. C. & Steinhauer, D. A. (1990). Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol 64, 3960-3962.
12. Ito, H., Watanabe, S., Takada, A. & Kawaoka, Y. (2001). Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol 75, 1576-1580.
13. Kajihara, M., Marzi, A., Nakayama, E., Noda, T., Kuroda, M., Manzoor, R., Matsuno, K., Feldmann, H., Yoshida, R. & other authors (2012). Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein. J Virol 86, 13467-13474.
14. Kuhn, J. H., Radoshitzky, S. R., Guth, A. C., Warfield, K. L., Li, W., Vincent, M. J., Towner, J. S., Nichol, S. T., Bavari, S. & other authors (2006). Conserved receptor-binding domains of Lake Victoria Marburgvirus and Zaire Ebolavirus bind a common receptor. J Biol Chem 281, 15951-15958.
15. Lee, J. E. & Saphire, E. O. (2009). Neutralizing Ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. Curr Opin Struct Biol 19, 408-417.
16. Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R. & Saphire, E. O. (2008). Structure of the Ebola virus glycoprotein bound to a human survivor antibody. Nature 454, 177-182.
17. Manicassamy, B., Wang, J., Jiang, H. & Rong, L. (2005). Comprehensive analysis of Ebola virus GP1 in viral entry. J Virol 79, 4793-4805.
18. Marzi, A., Yoshida, R., Miyamoto, H., Ishijima, M., Suzuki, Y., Higuchi, M., Matsuyama, Y., Igarashi, M., Nakayama, E. & other authors (2012). Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS ONE 7, e36192.
19. Matsuno, K., Kishida, N., Usami, K., Igarashi, M., Yoshida, R., Nakayama, E., Shimojima, M., Feldmann, H., Irimura, T. & other authors (2010). Different potential of C-type lectin-mediated entry between Marburg virus strains. J Virol 84, 5140-5147.
20. Nakayama, E. & Takada, A. (2011). Ebola and Marburg viruses. J Disast Res 6, 381-389.
21. Nakayama, E., Tomabechi, D., Matsuno, K., Kishida, N., Yoshida, R., Feldmann, H. & Takada, A. (2011). Antibody-dependent enhancement of Marburg virus infection. J Infect Dis 204 (Suppl. 3), S978-S985.
22. Negredo, A., Palacios, G., Vázquez-Morón, S., González, F., Dopazo, H., Molero, F., Juste, J., Quetglas, J., Savji, N. & other authors (2011). Discovery of an Ebolavirus-like filovirus in europe. PLoS Pathog 7, e1002304.
23. Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I. & Kawaoka, Y. (2002). Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 76, 406-410.
24. Neumann, G., Geisbert, T. W., Ebihara, H., Geisbert, J. B., Daddario-DiCaprio, K. M., Feldmann, H. & Kawaoka, Y. (2007). Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol 81, 2995-2998.
25. Olinger, G. G., Jr, Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S. D., Johnson, A. K. & other authors (2012). Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A 109, 18030-18035.
26. Qiu, X., Audet, J., Wong, G., Pillet, S., Bello, A., Cabral, T., Strong, J. E., Plummer, F., Corbett, C. R. & other authors (2012). Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 4, 138-81.
27. Reynard, O., Borowiak, M., Volchkova, V. A., Delpeut, S., Mateo, M. & Volchkov, V. E. (2009). Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 83, 9596-9601.
28. Rowe, C. L., Baker, S. C., Nathan, M. J. & Fleming, J. O. (1997a). Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J Virol 71, 2959-2969.
29. Rowe, C. L., Fleming, J. O., Nathan, M. J., Sgro, J. Y., Palmenberg, A. C. & Baker, S. C. (1997b). Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure. J Virol 71, 6183-6190.
30. Sanchez, A., Geisbert, T. W. & Feldmann, H. (2007). Filoviridae: Marburg and Ebola viruses. In Fields Virology, 5th edn, pp. 1409-1448. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
31. Schnell, M. J., Buonocore, L., Kretzschmar, E., Johnson, E. & Rose, J. K. (1996). Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A 93, 11359-11365.
32. Shedlock, D. J., Bailey, M. A., Popernack, P. M., Cunningham, J. M., Burton, D. R. & Sullivan, N. J. (2010). Antibody-mediated neutral-ization of Ebola virus can occur by two distinct mechanisms. Virology 401, 228-235.
33. Simmons, G., Wool-Lewis, R. J., Baribaud, F., Netter, R. C. & Bates, P. (2002). Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 76, 2518-2528.
34. Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A. & Kawaoka, Y. (1997). A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94, 14764-14769.
35. Takada, A., Feldmann, H., Stroeher, U., Bray, M., Watanabe, S., Ito, H., McGregor, M. & Kawaoka, Y. (2003). Identification of protective epitopes on Ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol 77, 1069-1074.
36. Takada, A., Fujioka, K., Tsuiji, M., Morikawa, A., Higashi, N., Ebihara, H., Kobasa, D., Feldmann, H., Irimura, T. & Kawaoka, Y. (2004). Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 78, 2943-2947.
37. Towner, J. S., Amman, B. R., Sealy, T. K., Carroll, S. A., Comer, J. A., Kemp, A., Swanepoel, R., Paddock, C. D., Balinandi, S. & other authors (2009). Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5, e1000536.
38. Volchkov, V. E., Volchkova, V. A., Stroher, U., Becker, S., Dolnik, O., Cieplik, M., Garten, W., Klenk, H. D. & Feldmann, H. (2000). Proteolytic processing of Marburg virus glycoprotein. Virology 268, 1-6.
39. Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L. & Hart, M. K. (2000). Epitopes involved in antibody-mediated protection from Ebola virus. Science 287, 1664-1666.
40. Wool-Lewis, R. J. & Bates, P. (1998). Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72, 3155-3160.
41. Wool-Lewis, R. J. & Bates, P. (1999). Endoproteolytic processing of the Ebola virus envelope glycoprotein: cleavage is not required for function. J Virol 73, 1419-1426.